A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-Term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men.
Latest Information Update: 20 Jan 2022
Price :
$35 *
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Registrational
- Sponsors Endo Pharmaceuticals Solutions
- 13 Jan 2022 According to an Endo media release, findings from this PK model and simulation by using data from this study were published in The Journal of Clinical Pharmacology.
- 29 Nov 2007 The NDA action date has been set for 27 Jun 2008.
- 07 Jun 2007 Status change from in progress to completed.